Podcasts about patients

About this episode: Robotic telesurgery allows providers to conduct minimally invasive surgeries across long distances, reaching remote communities. In this episode: Binita Ashar, a surgeon with a background in policy, discusses the revolutionary role this technology can play in medicine and what issues need to be addressed—from cost to cybersecurity—in order to greenlight more procedures in the United States. Guests: Binita Ashar, MD, MBA, is a general surgeon who previously served as the Director of the FDA's Office of Surgical and Infection Control Devices. She also serves on the board of the Society of Robotic Surgery. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Exclusive look at groundbreaking remote robotic surgery: Patient was in Africa; doctor was in Florida—ABC News WHO and Society of Robotic Surgery launch health innovation initiative to expand access to virtual care and telesurgery—WHO Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

This week, we look at new research on potassium optimization in patients with defibrillators, reducing antihypertensive therapy in nursing homes, an mRNA influenza vaccine, and belzutifan for rare neuroendocrine tumors. We review long QT syndrome and present a case of abnormal behavior and seizures in a young man. We also explore perspectives on primary care reform, tobacco cessation in HIV and tuberculosis care, corporate control in health care, and the simple power of compassion with ice cream.

Dr. Maria Janakos is a sports medicine physiatrist at NYU and a Clinical Assistant Professor at the NYU Grossman School of Medicine. She completed her residency at the University of Louisville and a Primary Care Sports Medicine Fellowship at Morristown Medical Center in New Jersey. Her clinical interests include concussion management, orthobiologics, musculoskeletal ultrasound, and event coverage. Dr. Janakos is actively involved in medical education at NYU, teaching medical students, residents, and fellows through lectures, hands-on training, and mentorship. At NYU, she is an active member of the NYU Concussion Center, where she regularly lectures on various concussion topics at both local and national levels. She specializes in the care of patients with acute concussions, treating individuals from adolescence through age 45. Part 2 The discussion included the following topics: challenges that patients face during the recovery period; factors determining treatment outcomes; preventing concussions; composition of the interdisciplinary treatment team; and the role of technology in treatment interventions.    

In this episode of The Health Advocates, host Steven Newmark breaks down what the recent federal government shutdown means for health care access and vulnerable patients. Then, he’s joined by Mahsa Pazokifard, a passionate patient advocate living with IgG4-related disease (IgG4-RD), a rare and often misunderstood autoimmune condition. Mahsa opens up about the challenges of getting diagnosed, how the disease has impacted her life and career, and why raising awareness is essential. Whether you’ve never heard of IgG4-RD or are living with a chronic illness yourself, this episode offers powerful insights into patient advocacy, rare disease awareness, and the human side of health care policy. To learn more about IgG4-Related Disease, visit: creakyjoints.org/igg4-rd-guide To learn more about vaccine recommendations and find reliable resources for patients, visit: ghlf.org/vaccines Contact Our Host Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org A podcast episode produced by Ben Blanc, Director, Digital Production and Engagement at GHLF. We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Listen to all episodes of The Health Advocates on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

This week on Health Matters, Courtney talks with Dr. Warren Ng, a psychiatrist at New York Presbyterian and Columbia, and the Community Health Director for the Center for Youth Mental Health at NewYork-Presbyterian. Dr. Ng explains what makes narcissistic traits distinct from narcissistic personality disorders, and offers an in-depth explanation of the symptoms and management strategies for navigating relationships with narcissists, whether colleagues, friends, or family members. ___Dr. Warren Ng is a psychiatrist for children, adolescents, and adults with an interest in HIV, public psychiatry, and family issues. He is the Medical Director of Outpatient Behavioral Health and the Director of clinical services for the Division of Child and Adolescent Psychiatry at Columbia University Irving Medical Center and NewYork-Presbyterian/Morgan Stanley Children's Hospital. He is also the NYP Behavioral Health Service Line Clinical Innovation Officer. He is the President of the American Academy of Child and Adolescent Psychiatry and has been past president of the New York Council on Child and Adolescent Psychiatry. He served on the Assembly and the Council on Children, Adolescents, and Families at the American Psychiatric Association (APA).___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

On this accredited episode of NP Pulse: The Voice of the Nurse Practitioner®️, expert faculty Drs. Korey Hood and Kathryn Evans-Kreider explore the psychosocial challenges of living with type 1 diabetes, with a focus on how nurse practitioners can support patients experiencing diabetes distress. Faculty discuss practical strategies, such as using brief screening tools, adopting person-first and strengths-based language and tailoring care through shared decision-making. The conversation also highlights the impact of SDOH and the importance of integrating mental health awareness into routine diabetes management. This podcast is part of the Clinical Advantage Bootcamp: Type 1 Diabetes Management Certificate for Nurse Practitioners. Visit the AANP CE Center to view the other modules. A participation code will be provided at the end of the podcast — make sure to write this code down. Once you have listened to the podcast and have the participation code, return to this activity in the AANP CE Center. Click on the "Next Steps" button of the activity and: 1. Enter the participation code that was provided. 2. Complete the posttest. 3. Complete the activity evaluation. This will award your continuing education (CE) credit and certificate of completion. 1.0 CE will be available through Nov. 30, 2027.   Tool link : Diabetes_Billing_and_Coding_Toolkit.pdf   This collaboration between AANP and Danatech, an Association of Diabetes Care and Education Specialists (ADCES) initiative, is made possible thanks to grants from Helmsley Charitable Trust, Abbott and Medtronic.

Send us a textCardiologist Dr. Michael Koren is joined by a 35-year-old patient "Tucker" to walk through his cardiovascular numbers and explain what it all means. The doctor explores a lipid profile and an advanced lipid profile from top to bottom, explaining everything from how LDL is calculated to what hs-CRP measures. Along the way, they discuss how diet, exercise, supplements, and medications can affect these numbers, how the numbers relate to your risk of a cardiovascular event (like a heart attack or stroke) and what, if any, interventions should be taken. This real-world-example shows how complex the world of cardiology and lipids is and gives helpful, actionable information based on the numbers you might see. This podcast is not medical advice, and all personal situations should be discussed with your physician.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Tina Liedtky, President of Transplant Diagnostics at Thermo Fisher Scientific, identifies the significant challenges in the US organ transplant system that must be addressed to meet the demand for organs.  Patient access to transplant care is hindered by geography, the need to match donors and recipients, and the threat of organ rejection. Living donations, particularly of kidneys and livers, are a solution to address the organ shortage, as organs from living donors often lead to better outcomes and can be scheduled to avoid damage caused by organ transportation. Tina explains, "So first of all, I would say that organ transplantation saves thousands of lives a year and gives patients with end-stage organ disease the ability to extend their lives meaningfully for many years. However, the organ transplant system in the US is not perfect, and it faces several real challenges. The most pressing challenge is a persistent imbalance between organ supply and demand, in that far more patients are in need of a lifesaving transplant than there are available organs, which leaves many patients waiting too long for a compatible organ or perhaps will never receive a compatible match. And unfortunately, for those patients left waiting, many get sicker, and often patients die while waiting on the wait list. So this gap in supply and demand is real, and it underscores the importance of living donation, which can help expand the pool of available organs and give patients a chance at the timely care that they need." "Another significant challenge is patient access to organ transplant care. For instance, in the weeks leading up to the transplant procedure and after the procedure, patients are often required to be living or situated near the hospital or the transplant center where the surgery is performed. This can pose a challenge to those who simply don't reside in areas where there are major transplant centers or who can't afford temporary housing. And that creates a socioeconomic inequity when it comes to access." #ThermoFisherScientific #Transplantation #OrganDonors #LivingDonation #HeartTransplant #OrganTransplants thermofisher.com Download the transcript here

Tina Liedtky, President of Transplant Diagnostics at Thermo Fisher Scientific, identifies the significant challenges in the US organ transplant system that must be addressed to meet the demand for organs.  Patient access to transplant care is hindered by geography, the need to match donors and recipients, and the threat of organ rejection. Living donations, particularly of kidneys and livers, are a solution to address the organ shortage, as organs from living donors often lead to better outcomes and can be scheduled to avoid damage caused by organ transportation. Tina explains, "So first of all, I would say that organ transplantation saves thousands of lives a year and gives patients with end-stage organ disease the ability to extend their lives meaningfully for many years. However, the organ transplant system in the US is not perfect, and it faces several real challenges. The most pressing challenge is a persistent imbalance between organ supply and demand, in that far more patients are in need of a lifesaving transplant than there are available organs, which leaves many patients waiting too long for a compatible organ or perhaps will never receive a compatible match. And unfortunately, for those patients left waiting, many get sicker, and often patients die while waiting on the wait list. So this gap in supply and demand is real, and it underscores the importance of living donation, which can help expand the pool of available organs and give patients a chance at the timely care that they need." "Another significant challenge is patient access to organ transplant care. For instance, in the weeks leading up to the transplant procedure and after the procedure, patients are often required to be living or situated near the hospital or the transplant center where the surgery is performed. This can pose a challenge to those who simply don't reside in areas where there are major transplant centers or who can't afford temporary housing. And that creates a socioeconomic inequity when it comes to access." #ThermoFisherScientific #Transplantation #OrganDonors #LivingDonation #HeartTransplant #OrganTransplants thermofisher.com  Listen to the podcast here

'Heidi' records consultations and automatically creates draft clinical notes, referral letters, and follow-up summaries for doctors to review and approve. Dr Benjamin Pearson is Hawke's Bay's Chief Medical Officer spoke to Corin Dann.

Observational Cinematic Compulsion Disorder, or OCCD, is a common behavioral condition characterized by involuntary ocular fixation on a neighbor's in-flight audiovisual LCD display, even in the absence of accompanying auditory stimuli. Patients with OCCD exhibit vastly impaired concentration filtration, resulting in reflexive visual tracking of narrative cinematic sequences presented on adjacent personal screens during commercial air travel. The disorder is frequently associated with heightened situational distractibility, transient dissociative drift, and a paradoxical increase in attentional salience toward media not voluntarily selected by the patient. Management of OCCD involves admission to a 19th-century gothic asylum in upstate New York, with current clinical guidelines emphasizing electroconvulsive therapy administered on a daily basis, leading to a positive outcome of preemptive engagement with self-selected entertainment to mitigate cross-screen visual intrusion. This episode is brought to you by BetterHelp. Give online therapy and get on your way to being your best self at https://Betterhelp.com/BALD For a limited time get 40% off your first box PLUS get a free item in every box for life, by using promo code BALD at: https://Hungryroot.com/BALD To get simple, online access to personalized, affordable care for ED, Hair Loss, Weight Loss, and more, go to: https://Hims.com/BALD Find out why Nutrafol is the best-selling hair growth supplement brand by using promo code BALD at: https://Nutrafol.com The Holidays are here! Don't miss out on early Black Friday deals at Wayfair! Hurry, as the sale ends December 7th! For up to 70%off, head to: https://Wayfair.com Follow Trixie: @TrixieMattel Follow Katya: @Katya_Zamo To watch the podcast on YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://bit.ly/TrixieKatyaYT⁠ To check out our official YouTube Clips Channel: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/TrixieAndKatyaClipYT⁠ Don't forget to follow the podcast for free wherever you're listening or by using this link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/thebaldandthebeautifulpodcast⁠ If you want to support the show, and get all the episodes ad-free go to: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://thebaldandthebeautiful.supercast.com⁠ To check out future Live Podcast Shows, go to: ⁠⁠https://trixieandkatya.com/#tour⁠ To check out the Trixie Motel in Palm Springs, CA: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.trixiemotel.com⁠ Listen Anywhere! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://bit.ly/thebaldandthebeautifulpodcast⁠ Follow Trixie: Official Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.trixiemattel.com⁠ TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@trixie⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/trixiemattel⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/trixiemattel⁠ Twitter (X): ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/trixiemattel⁠   Follow Katya: Official Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.welovekatya.com⁠ TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@katya_zamo⁠ Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/welovekatya⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/katya_zamo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter (X): ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/katya_zamo⁠   #TrixieMattel #KatyaZamo #BaldBeautiful Learn more about your ad choices. Visit podcastchoices.com/adchoices

On a warm June afternoon in 1868, a 24-year-old woman accepted a glass of lemonade from her nurse at a Geneva boarding house. Within moments, her pupils dilated grotesquely, her heart pounded violently, and reality dissolved into nightmare. That glass of lemonade broke open one of Switzerland's most disturbing criminal cases.SEASON & EPISODE CONTEXTThis is Episode 9 of Foul Play Season 36: "Serial Killers in History," examining murderers from ancient times through the early 1900s. This season explores 15 cases spanning centuries and continents, revealing how serial murder predates modern criminology by millennia.THE CASE SUMMARYBetween 1865 and 1868, Marie Jeanneret worked as a private nurse in Geneva and surrounding areas of Switzerland, moving between respectable boarding houses and private hospitals. Everywhere she went, patients died under mysterious circumstances. Eleven-year-old children. Elderly widows. Entire families.Her method was both calculated and cruel. She used cutting-edge poisons for the 1860s—plant alkaloids like atropine from belladonna and morphine from opium poppies. These substances were so difficult to detect in corpses that she might never have been caught. She offered candy she called "princesses" to children. She served sweetened water to friends. She predicted deaths days before they happened—not because she had medical insight, but because she knew exactly when the poison would finish its work.When authorities finally exhumed the bodies in 1868, they found chemical signatures of murder in decomposing tissue. The trial revealed at least six confirmed murders and perhaps thirty attempted murders. But the verdict the jury reached would create one of criminal history's most profound paradoxes—her case helped abolish the death penalty in Geneva three years later.THE VICTIMSMarie Jeanneret's victims weren't random—they were people who trusted her completely during their most vulnerable moments:Marie Grétillat, 61, hired Jeanneret for what should have been a minor illness. She died in February 1867 after weeks of escalating agony.Sophie Juvet, 58, died in September 1867 at the Maison de Santé hospital where Jeanneret worked as a nurse.Jenny-Julie Juvet, Sophie's daughter, was only 11 years old. She loved candy and trusted the nurse who brought her special bonbons called "princesses." Before she died in January 1868, she begged her family not to let the nurse near her anymore. They thought she was delirious. She wasn't—she knew.Auguste Perrod (around 80), Louise-Marie Lenoir (72), Madame Hahn, Demoiselle Gay, Demoiselle Junod, Julie Bouvier, and Jacques Gros (Julie's father) all died under Jeanneret's care between 1867 and 1868.KEY CASE DETAILSTHE METHOD: Jeanneret used belladonna (deadly nightshade) and morphine as her primary weapons. Belladonna poisoning produces distinctive symptoms: grotesquely dilated pupils, rapid heartbeat, extreme light sensitivity, terrifying hallucinations, and eventually seizures and respiratory failure. Morphine suppresses breathing until victims simply stop inhaling—the death looks peaceful but is actually suffocation.As a nurse, she had legitimate access to these substances and professional cover for every action. She mixed poisons into sweet items—lemonade, sweetened water, candy—because sugar masks the bitter taste effectively. For some victims, she administered lower doses over time, creating slow declines that mimicked natural illness. For others, she used massive doses intended to kill quickly.THE BREAKTHROUGH: The case broke open when Marie-Catherine Fritzgès, 24, survived a belladonna poisoning in June 1868. Her doctor recognized the symptoms immediately and contacted authorities. Police searched Jeanneret's rooms and found bottles of belladonna extract, containers of morphine, and detailed nursing notes documenting every symptom, decline, and death—inadvertently documenting her own crimes.HISTORICAL CONTEXT & SOURCESThe 1860s represented a turning point in forensic medicine. Swiss medical examiners used groundbreaking techniques to test tissue samples for alkaloid compounds in exhumed bodies—finding chemical signatures consistent with belladonna and morphine poisoning. This case marked one of the first instances where forensic medicine played a crucial role in securing a conviction in Switzerland.The trial opened in Geneva in late 1868 with overwhelming evidence: poisoned bodies, survivors' testimony, bottles of poison, and Jeanneret's own nursing notes. On November 19, 1868, the jury returned a stunning verdict—guilty on all counts, but they recommended clemency. Instead of execution, Jeanneret received life imprisonment with hard labor.Three years later, in 1871, the Canton of Geneva abolished the death penalty. Jeanneret's case was cited as a key example—a jury had looked at overwhelming evidence of serial murder and chosen mercy over execution.RESOURCES & FURTHER READINGSwiss criminal history archives maintain extensive records of the Jeanneret case, including original trial transcripts and forensic reports that revolutionized poison detection methods. The case remains a standard reference in medical ethics courses throughout Europe, illustrating the catastrophic consequences of betrayed medical trust.The Geneva State Archives houses original court documents from the 1868 trial. Swiss forensic medicine institutes continue to study the case as a landmark example of early toxicology and the systematic safeguards developed in response to healthcare serial killers.RELATED FOUL PLAY EPISODESIf you found this episode compelling, explore other Foul Play cases involving Victorian-era poisoners and medical professionals who betrayed their sacred trust. Season 36 examines serial killers throughout history, from ancient Rome through the early 1900s, revealing how murder predates modern criminology and how society responded to unimaginable crimes.Each episode of Foul Play combines meticulous historical research with victim-centered storytelling, honoring those whose lives were taken while examining the criminals who took them.THE LEGACYMarie Jeanneret's crimes fundamentally transformed Switzerland's approach to medical safety and criminal investigation. The case exposed critical gaps in poison control, leading to strict measures including detailed record-keeping of sales and mandatory identification checks. Background checks for medical staff became more thorough, references were more carefully vetted, and supervision was enhanced throughout Europe.Perhaps most significantly, Jeanneret's case transformed public consciousness about the nature of evil. The idea that a healthcare professional could systematically murder patients while maintaining an appearance of respectability forced society to confront uncomfortable truths. The poisoner who took at least six lives became part of the movement that saved countless others from execution—the most paradoxical legacy imaginable.ABOUT FOUL PLAYFoul Play examines history's most compelling true crime cases with meticulous research and sophisticated storytelling. Hosts Shane Waters and Wendy Cee explore serial killers from ancient Rome through the early 1900s, focusing on victim-centered narratives that honor the dead rather than sensationalizing killers. Each episode combines atmospheric period detail with rigorous historical accuracy, transporting listeners to crimes that shaped criminal justice systems across centuries and continents.CONNECT WITH FOUL PLAYNew episodes release every Tuesday at 5:00 AM EST. Follow Foul Play on social media for behind-the-scenes research, historical context, and episode updates. Visit our website for complete episode archives, source lists, and additional resources about the cases we cover.CONTENT WARNINGThis episode contains detailed descriptions of poisoning, murder of children, and medical betrayal. Listener discretion is advised. If you or someone you know needs support, resources are available through crisis helplines and mental health services.Support this podcast at — https://redcircle.com/foul-play-crime-series/donationsAdvertising Inquiries: https://redcircle.com/brands

EPISODE DESCRIPTIONBefore she was raising millions to preserve fertility for cancer patients, Tracy Weiss was filming reenactments in her apartment for the Maury Povich Show using her grandmother's china. Her origin story includes Jerry Springer, cervical cancer, and a full-body allergic reaction to bullshit. Now, she's Executive Director of The Chick Mission, where she weaponizes sarcasm, spreadsheets, and the rage of every woman who's ever been told “you're fine” while actively bleeding out in a one-stall office bathroom.We get into all of it. The diagnosis. The misdiagnosis. The second opinion that saved her life. Why fertility preservation is still a luxury item. Why half of oncologists still don't mention it. And what it takes to turn permission to be pissed into a platform that actually pays for women's futures.This episode is blunt, hilarious, and very Jewish. There's chopped liver, Carrie Bradshaw slander, and more than one “fuck you” to the status quo. You've been warned.RELATED LINKSThe Chick MissionTracy Weiss on LinkedInFertility Preservation Interview (Dr. Aimee Podcast)Tracy's Story in Authority MagazineNBC DFW FeatureStork'd Podcast EpisodeNuDetroit ProfileChick Mission 2024 Gala RecapFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Contributor: Aaron Lessen MD Educational Pearls:  Recent prospective randomized clinical trial assessed optimal head-of-bed positioning in patients with LVO 0º vs. 30º elevation Objective was to determine superiority of the two angles in stability prior to thrombectomy for LVO patients 45 patients randomized to the group with 0° head positioning and 47 patients randomized to the group with 30° head positioning Patients in the 30º group experienced worsening of NIHSS by 2 points or more Patients with head position at 0° showed score stability Hazard ratio 34.40; 95% CI, 4.65-254.37; P 

Every chiropractor wants patients who stay committed, not just until the pain fades, but for life. Dr. Tabor Smith reveals how a clear spinal-hygiene system turns that vision into reality. He shares the habits, structure, and mindset that help teams lead with certainty and patients take ownership of their care. This conversation dives into how simple daily systems can improve outcomes, prevent degeneration, and build real retention without adding complexity. You'll also learn how to empower your team with training that drives compliance, consistency, and conviction so your entire practice grows from purpose, not pressure.In this episode you will:Learn how to install a spinal-hygiene system that improves compliance and outcomes.Discover the four daily movements that protect the spine and increase patient buy-in.See how to connect hygiene education with patient retention and reactivation.Understand how to train your team to speak with certainty and consistency.Explore how a “dental model” for spinal care scales practice growth sustainably. Episode Highlights02:25 – Learn how a “tip-of-the-spear” mindset keeps chiropractors leading with conviction and purpose.03:45 – See why uniting passion with structure helps practices grow without chaos.05:42 – Understand why spinal hygiene fits every chiropractic technique and drives long-term retention.07:49 – Hear how the vision for spinal hygiene parallels dentistry's success in creating daily habits.08:36 – Discover how modern posture and technology accelerate spinal degeneration—even in teens.10:45 – Clarify the patient's role in lifelong spinal care versus the chiropractor's responsibility for checkups.15:13 – Learn what research reveals about how degeneration starts and how to reverse engineer prevention.19:37 – Explore how lifestyle habits influence 40 percent of spinal health outcomes.20:14 – Understand the “two-week rule” showing when immobilized joints begin arthritic change.24:31 – Introduce four core spinal-hygiene exercises every patient can safely perform at home.26:36 – Target C5 and L4-L5—the two areas most prone to degeneration—and how to protect them daily.27:50 – Use the “why” behind spinal hygiene to dramatically increase patient compliance.31:06 – Train tone, empathy, and certainty so your team converts through genuine care, not scripts.33:25 – Model home-care consistency across your team to raise accountability and results.36:36 – Simplify rollout with ready-made hygiene kits and see how the system runs itself.40:05 – Hear about the Certified Spinal Hygienist giveaway and how to enter for your full team.46:48 – Catch the closing reminder on how to email Dr. Tabor to join the draw before it closes.47:12 - Dr. Kale talks with Success Partners Dr. Andrew Wells and Dr. Chad Woolner from Simplified Functional Medicine about how chiropractors can add functional medicine without adding more work or complexity. They share the personal health challenges that led them into the field and why so many chiropractors struggle to deliver it on their own. They outline how their team-driven system keeps chiropractic central, protects a CEO's time, and creates strong clinical and financial results. It's a powerful look at what's possible when you simplify and step into your next level of impact. Resources MentionedLearn more about the TRP Remarkable Business Immersion - March 6 - 7, 2026 in Phoenix, AZ and March 20 - 21, 2026 in Brisbane, AUS - https://theremarkablepractice.com/upcoming-events/To learn more about the REM CEO Program, please visit:http://www.theremarkablepractice.com/rem-ceoFor more information about Simplified Functional Medicine please visit:  https://simplifiedfunctionalmedicine.com/Book a Strategy Session with Dr. Pete - https://go.oncehub.com/PodcastPCPrefer to watch? Catch the podcast on YouTube at: https://www.youtube.com/@TheRemarkablePractice1To listen to more episodes, visit https://theremarkablepractice.com/podcastor follow on your favorite podcast app.

Heavy Slow Resistance Training Combined with Patient Education in Patients with Gluteal Tendinopathy: A Feasibility Study Grigat JM, Kjeldsen T, Jørgensen SL, et al. Musculoskelet Sci Pract. Published online September 2025:103425. doi:10.1016/j.msksp.2025.103425 Due to copyright laws, unless the article is open source we cannot legally post the PDF on the website for the world to download at will. Brought to you by our sponsors at: CSMi – https://www.humacnorm.com/ptinquest VALD MoveHealth - https://movehealth.me/ Learn more about/Buy Erik/Jason/Chris's courses – The Science PT Support us on the Patreons! Music for PT Inquest: "The Science of Selling Yourself Short" by Less Than Jake Used by Permission Other Music by Kevin MacLeod – incompetech.com: MidRoll Promo – Mining by Moonlight Koal Challenge – Sam Roux  

Every Comic-Con, the guys have a few new friends who hang around, waiting for the right moment to jump on the mic. NO ONE ever waited as long (and as patiently) as new buddy Arturo, a man so prepared for NTS, that he brought his own chair. Yes, really.  -- #comedypodcast #humorpodcast #funnypodcast #darkhumor #podernfamily #RICC2025 #ComicCon #ricomiccon www.needlesstosaypodcast.com www.ntspodcastgear.com

Join @coach.noush_dpt as she dive's into the article "Exploration of combined physical activity and music for patients with Alzheimer's disease: A systematic review".  If you found this content helpful, go to https://PTonICE.com to check out our collection of Free Resources like the MMOA Digest our Bi-Weekly Research Email that goes out to thousands of clinicians.

Mitchell Thornbrugh, CIO and director of the Office of Information Technology at the Indian Health Service (IHS), is leading a transformative effort to modernize health care delivery for Native American and Alaska Native communities. Patients at the Heart Electronic Health Record (PATH EHR) is an enterprise-wide initiative uniting more than 200 staff from federal, tribal and urban health facilities. At the core of Thornbrugh's vision is an understanding that rural and underserved areas face distinct health care challenges, including limited resources and workforce shortages. By approaching EHR modernization through the lens of community impact, IHS is positioning itself as a leader in redefining how digital health serves patients across vast and diverse regions. Thornbrugh emphasizes that the true breakthrough lies in data liberation — unlocking decades of health records to improve outcomes and guide smarter decision-making. This patient-first, data-driven approach ensures PATH EHR is not only a milestone for Native health systems today but also a blueprint for health care transformation for generations to come.

In this episode, Gianna Beasley hosts a discussion with guests Mike Donnelly-Boylen and Zach Niemiec about their experiences at ObesityWeek. They share insights on the latest advancements in obesity treatment, the importance of patient advocacy, and the role of social media in spreading awareness. The conversation highlights the need for personalized care and the impact of policy changes on medication accessibility.TakeawaysObesity is a disease, not a personal failure.Patient advocacy is crucial for policy changes.Social media plays a key role in spreading awareness.Personalized care is essential for effective treatment.Policy changes can improve medication accessibility.ObesityWeek offers insights into the latest treatments.Patients' voices are vital in healthcare discussions.The stigma around obesity needs to be addressed.Networking at conferences can enhance advocacy efforts.Healthcare providers should engage more on social media.Follow Mike & Zach:Mike: https://www.tiktok.com/@mike.onamission2?_r=1&_t=ZT-91VOG00b859Zach: https://www.tiktok.com/@lucky_finz?_r=1&_t=ZT-91VOYHpIOWNKeywords

Adenomyosis is a condition in which the uterine lining grows into the muscular wall of the uterus, often causing heavy menstrual bleeding, severe cramping, and chronic pelvic pain. It is estimated to affect 25–60% of women worldwide. Despite its prevalence, treatment options in North America remain extremely limited. Many patients are forced to choose between long-term opioid pain management or a hysterectomy, options that can significantly impact quality of life. In this episode of Curing with Sound, we speak with Dr. Vanda Corbett, a healthcare practitioner who endured decades of debilitating adenomyosis-related pain before discovering focused ultrasound. She first learned about this noninvasive treatment after listening to an episode of the Not Your Mother's Menopause podcast featuring Suzanne LeBlang, MD, the Foundation's Director of Clinical Relationships.  Determined to find an alternative to surgery or opioids, Dr. Corbett made the life-changing decision to travel from Dubai to Chongqing Haifu Hospital in China for a focused ultrasound procedure. Her transformative experience has motivated her to share her story, so more women can learn about this revolutionary noninvasive treatment option. Discussion highlights: Medical Travel Experience: Follow Dr. Corbett's journey from Dubai to Chongqing, including the preparation process, travel logistics, and the patient-centered care she received at a specialized focused ultrasound hospital. Immediate Treatment Results and Advocacy Mission: Discover how Dr. Corbett experienced complete pain relief within hours of her procedure, shifting from decades of debilitating symptoms to a return to normal daily life. Learn about her mission to raise awareness of adenomyosis and the potential of focused ultrasound through storytelling and social media. Watch Dr. Corbett's documentary videos tracking her journey with Adenomyosis and her focused ultrasound treatment. Listen to Dr. Corbett's podcast interview on Dr. Lovely's Not Your Mother's Menopause podcast, where she discusses treating Adenomyosis with focused ultrasound. Listen to Dr. Susie LeBlang's podcast interview on Dr. Lovely's Not Your Mother's Menopause podcast, where she discusses treating uterine fibroids with focused ultrasound. EPISODE TRANSCRIPT ---------------------------- QUESTIONS? Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances.  Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation.  FUSF SOCIAL MEDIA LinkedIn X Facebook Instagram TikTok YouTube FUSF WEBSITE https://www.fusfoundation.org SIGN UP FOR OUR FREE NEWSLETTER https://www.fusfoundation.org/newsletter-signup/ READ THE LATEST NEWSLETTER https://www.fusfoundation.org/the-foundation/news-media/newsletter/ DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK) https://www.fusfoundation.org/read-the-tumor-by-john-grisham/  

Welcome to To the Point Cybersecurity podcast, brought to you by Forcepoint! This week, hosts Rachael Lyon and Jonathan Knepher are joined by Dr. Christian Dameff, the nation's very first Medical Director of Cybersecurity at UC San Diego Health. Dr. Dameff brings a unique perspective to the evolving intersection of healthcare, patient safety, and cybersecurity—combining his experience as an emergency physician, clinical informaticist, and self-proclaimed lifelong hacker. In this episode, we dive into the critical challenges faced by healthcare organizations, from bridging the gap between CISOs and clinical staff to the urgent realities of cyberattacks that threaten patient outcomes. Dr. Dameff shares real-world stories and research about the very tangible impact of ransomware on hospitals and patient care, emphasizing the need for interdisciplinary collaboration and evidence-based solutions. Whether you're a cybersecurity professional, a healthcare provider, or just interested in how digital threats are reshaping medicine, this episode promises insights into the balancing act between innovation, security, and saving lives. Hit play, subscribe, and join us as we get to the point—where cybersecurity meets patient care! For links and resources discussed in this episode, please visit our show notes at https://www.forcepoint.com/govpodcast/e359

By Adam Turteltaub The rise of generative AI has brought transformative potential to healthcare—from streamlining administrative tasks to supporting clinical decision-making. But alongside these benefits comes a growing concern: Shadow AI. Alex Tyrrell, Chief Technology Officer, Health at Wolters Kluwer explains in this podcast that this term refers to the use of unauthorized, unmonitored AI tools within organizations. In healthcare, where data privacy and patient safety are paramount, Shadow AI presents a unique and urgent challenge both now and in the future. Healthcare professionals often turn to generative AI tools with good intentions—hoping to reduce documentation burdens, improve workflows, or gain insights from complex data. However, many of these tools are unproven large language models (LLMs) that operate as black boxes. They're prone to hallucinations, lack transparency in decision-making, and may inadvertently expose Protected Health Information (PHI) to the open internet. This isn't just a theoretical risk. The use of public AI tools on personal devices or in clinical settings can lead to serious consequences, including: Privacy violations Legal and regulatory non-compliance Patient harm due to inaccurate or misleading outputs Despite these risks, many healthcare organizations lack visibility into how and when these tools are being used. According to recent data, only 18% of organizations have a formal policy governing the use of generative AI in the workplace, and just 20% require formal training for employees using these tools. It's important to recognize that most employees aren't using Shadow AI to be reckless—they're trying to solve real problems. The lack of clear guidance, approved tools, and education creates a vacuum that Shadow AI fills. Without a structured approach, organizations end up playing a game of whack-a-mole, reacting to issues rather than proactively managing them. So, what can healthcare organizations do to address Shadow AI without stifling innovation? Audit and Monitor Usage Start with what you can control. For organization-issued devices, conduct periodic audits to identify unauthorized AI usage. While personal devices are harder to monitor, you can still gather feedback from employees about where they see value in generative AI. This helps surface use cases that can be addressed through approved tools and structured programs. Procure Trusted AI Tools Use procurement processes to source AI tools from vetted vendors. Look for solutions with: Transparent decision-making processes Clear documentation of training data sources No use of patient data or other confidential information for model training Avoid tools that lack explainability or accountability—especially those that cannot guarantee data privacy. Establish Structured Governance Governance isn't just about rules—it's about clarity and oversight. Develop a well-articulated framework that includes: Defined roles and responsibilities for AI oversight Risk assessment protocols Integration with existing compliance and IT governance structures Make sure AI governance is not siloed. Those managing AI tools should be at the table during strategic planning and implementation. Educate and Engage Education is the cornerstone of responsible AI use. Employees need to understand not just the risks, but also the right way to use AI tools. Offer formal training, create open forums for discussion, and build a culture of transparency. When people feel informed and supported, they're more likely to choose safe, approved tools. Protect PHI with Precision In clinical workflows, PHI is often unavoidable. That's why it's critical to: Deidentify patient data whenever possible Ensure only authorized systems, processes, and personnel have access to PHI Maintain up-to-date business associate agreements and data processing contracts

A casual conversation at CrossPointe Coast about the scripture and sermon from the previous Sunday with Jeremiah Fyffe & Sam Powers. You Rich James 5:7-20 Special Guest: Sam Powers.

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In the final part of this 3-part series, Dr Terris discussed how the early diagnosis of bladder cancer presents a significant challenge, particularly in female patients, who are frequently diagnosed at a later stage of the disease and subsequently respond less favorably to treatment modalities. A crucial component of early detection is the rigorous evaluation of hematuria, she emphasized. Microhematuria is defined strictly by microscopy. Reliance solely on a dipstick test is insufficient; any positive dipstick result necessitates a microscopic examination, she explained. Furthermore, patients currently receiving anticoagulation therapy do not bypass the standard workup, she noted. If hematuria is identified alongside a urinary tract infection or gynecological issue, the urine should be rechecked once the co-existing problem has cleared, she advised. Risk assessment must consider both common and less-recognized factors, particularly in women, according to Terris. Standard risks include exposure to cyclophosphamide or ifosfamide, Lynch syndrome, chronic indwelling Foley catheters, benzene/aromatic amine exposure, and smoking, she added. However, uro-oncologists must actively assess female patients for occupational exposures not traditionally associated with bladder cancer, she said. Patients presenting with microhematuria should be stratified into low-, intermediate-, or high-risk groups, Terris continued. The gold standard evaluation for high-risk patients is a cystoscopy and CT urogram, she reported. The CT urogram involves cross-sectional imaging of the abdomen and pelvis with and without contrast, incorporating delayed images to optimally visualize the renal pelvis and ureters for potential filling defects, she noted. If patients cannot tolerate contrast, an MR urogram is the primary alternative, she stated. If neither CT nor MR urogram can be performed, the default workup is non-contrast CT combined with cystoscopy and retrograde pyelograms, although this requires general anesthesia, she explained. Given that women are often diagnosed with bladder cancer late and face poor outcomes with advanced disease, maintaining a heightened awareness and low threshold for investigation is critical, Terris concluded.

It's often said that “words matter.”And hospital patient status assignment is no exception. What do your teams say when a patient is in inpatient status which isn't supported?  How about the reverse: when a patient is in outpatient status with observation services. Can your team change to inpatient? Words matter, and Dr. Juliet Ugarte Hopkins, chief medical officer for Phoenix Medical Management, Inc., will explain precisely how impactful your choices can be.During the next live edition of Talk Ten Tuesday, Dr. Juliet Ugarte Hopkins will report on this timely topic.The broadcast will also feature these instantly recognizable panelists, who will report more news during their segments:Social Determinants of Health: Tiffany Ferguson, CEO for Phoenix Medical Management, Inc., will report on the news that is happening at the intersection of medical record auditing and the SDoH.CDI Report: Cheryl Ericson, Senior Director of Clinical Policy and Education for the vaunted Brundage Group, will have the latest CDI updates.The Coding Report: Christine Geiger, Assistant Vice President of Acute and Post-Acute Coding Services for First Class Solutions, will report on the latest coding news.News Desk: Timothy Powell, ICD10monitor national correspondent, will anchor the Talk Ten Tuesdays News Desk.

Dr Kevin J. Tracey reveals the extraordinary impact the vagus nerve, which connects every organ in the body to the brain, has on our health. Kevin has been a pioneer in the use of bioelectronic devices to stimulate this nerve  to treat a range of auto-immune illnesses and he is the author of a new book The Great Nerve, The New Science of the Vagus Nerve and How to Harness its healing reflexes, published by Penguin Life. Patient trials have shown that remarkably, we can electrically stimulate the vagus nerve to ameliorate the symptoms of conditions such as rheumatoid arthritis and multiple sclerosis. While Kevin is clear the treatment won't work for everyone, for some patients the results have been truly remarkable enabling them to  walk unaided again for first time in decades and get back a quality of life they thought was gone for ever. And for all of us, it now appears that lifestyle interventions such as cold showers, meditation and how we breathe, may offer critically important strategies to effectively regulating our vagus nerve and so maximises its  impact on our health. You can find out more about this podcast on its website and if you would like to support it you can do so via Patreon at or via PayPal. The host of the podcast, Liz Tucker is an award winning medical journalist and former BBC producer and director.  You can follow Liz on X and read further information about the podcast on her Substack newsletter. Medical Evidence Matters with Liz Tucker has been selected by Feedspot as one of the top 15 UK Medical Podcasts https://blog.feedspot.com/uk_medical_podcasts/

In this episode of the Kidney Stone Diet Podcast, hosts Jeff Sarris and Jill Harris discuss the challenges and fears associated with traveling while having a kidney stone. Jill shares her personal experiences and offers practical advice for those concerned about traveling with kidney stones, including the importance of consulting with a doctor, preparing a travel first aid kit, and considering trip insurance. The conversation emphasizes the need for patients to be proactive in their healthcare and to ask the right questions during doctor visits.TakeawaysTraveling with a kidney stone can be very stressful.Consult your doctor about the location and size of your kidney stone before traveling.Packing a first aid kit can help manage potential kidney stone pain while traveling.Trip insurance is advisable for those with medical conditions like kidney stones.Patients should prepare questions for their doctor visits to maximize the effectiveness of the appointment.Understanding the risks associated with kidney stones can alleviate travel anxiety.It's important to know that not all kidney stones will move during travel.Having a plan in place can help reduce fear when traveling with a kidney stone.Traveling with a kidney stone requires careful planning and preparation.Being informed about your condition can empower you to make better health decisions.00:00 Traveling with Kidney Stones: A Scary Reality06:39 Preparing for Doctor's Visits and Travel Insurance——HAVE A QUESTION? _Leave us a voicemail at (773) 789-8764.KIDNEY STONE DIET® APPROVED PRODUCTSProtein Powders, Snacks, and moreWORK WITH JILL _Start HereKidney Stone Diet® All-Access PassKidney Stone Diet® CourseKidney Stone Diet® Meal PlansKidney Stone Diet® BooksPrivate Consultation with JillOne-on-One Deep Dive24-Hour Urine AnalysisSUPPORT THE SHOW _Join the PatreonRate Kidney Stone Diet on Apple Podcasts or Spotify——WHO IS JILL HARRIS? _Since 1998, Jill Harris has been the #1 kidney stone prevention nurse helping patients reduce their kidney stone risk. Drawing from her work with world-renowned University of Chicago nephrologist, Dr. Fred Coe, and the thousands of patients she's worked with directly, she created the Kidney Stone Diet®. With a simple, self-guided online video course, meal plans, ebooks, group coaching, and private consultations, Kidney Stone Diet® is Jill's effort to help as many patients as possible prevent kidney stones for good.

In this episode of 'Confessions of a Terrible Leader', Layci Nelson speaks with Dana Sherwin about her framework, the Thinking Patient, which empowers individuals to take charge of their healthcare. Dana shares her personal health journey, emphasizing the importance of patient engagement, preparation, and effective communication with healthcare providers. The conversation highlights the need for patients to be proactive, ask questions, and participate actively in their health decisions, ultimately leading to better health outcomes. Dana also reflects on her leadership experiences and the lessons learned from her health challenges.Takeaways:Being engaged in your care leads to better health outcomes.Preparation is crucial for effective communication with healthcare providers.Patients should be the CEO of their own health.Understanding medical language enhances patient advocacy.Asking questions is essential for informed health decisions.Courage in healthcare can be built gradually.Active participation in appointments improves patient experiences.Trustworthy health information comes from reputable sources.Communication skills are vital for healthcare leaders.Learning from personal health experiences can inform better patient care.Chapters00:00 Introduction to the Thinking Patient Framework02:55 Dana's Personal Health Journey06:00 The Importance of Patient Engagement08:57 Preparing for Medical Appointments11:38 Understanding Medical Language15:00 The Art of Questioning17:40 Active Participation in Healthcare20:42 Building Courage in Health Advocacy23:39 Dana's Leadership Confession26:38 Conclusion and ResourcesEPISODE LINKS:https://www.thethinkingpatient.com/abouthttps://www.linkedin.com/in/desherwin/

A new JAMA Internal Medicine study reveals that Trump's NIH funding cuts have abruptly halted nearly 400 clinical trials, leaving more than 74,000 patients — especially those in underserved communities — without essential care and research options. Subscribe to our newsletter to stay informed with the latest news from a leading Black-owned & controlled media company: https://aurn.com/newsletter Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textHow far can AI go in helping us diagnose disease—without losing the human judgment patients rely on?In this episode, I break down four studies shaping the future of digital pathology, oncology, and neurology. From spatial biology updates at SITC to voice-based Alzheimer's detection, deep learning for sarcoma prognosis, and new guidelines for safe AI deployment, this week's digest highlights where AI is making a real impact—and where caution still matters.Episode Highlights1️⃣ SITC Trends & Spatial Biology (00:00 → 07:40)I share key updates from SITC 2025, including the growing role of multiplex immunofluorescence (mIF) and the need for integrated staining-to-scanning workflows. I also preview new educational content and upcoming podcast guests in global AI research.2️⃣ Digital Neuropathology & Alzheimer's (07:40 → 13:01)A major review confirms that digital neuropathology is now robust enough for large-scale Alzheimer's studies—opening doors for computational tools to link histology with cognition.3️⃣ Patient Safety in AI (13:01 → 19:56)An Italian review underscores the foundations of trustworthy AI: dataset quality, transparency, oversight, and continuous validation. I discuss why “patient-centered AI” must remain our standard.4️⃣ Voice Biomarkers for Cognitive Decline (19:56 → 26:43)AI models analyzing short speech recordings are showing high accuracy for early Alzheimer's detection. This could make future screening simple, noninvasive, and more accessible.5️⃣ Deep Learning for Sarcoma Prognosis (34:06 → 35:59)A multi-instance CNN outperforms FNCLCC grading by identifying prognostic patterns in tumor center and periphery regions, offering new insights into soft-tissue sarcoma biology.TakeawaysmIF is maturing quickly but needs standardized, end-to-end workflows.Digital neuropathology is ready for broader Alzheimer's research.Safe AI requires multidisciplinary collaboration and rigorous validation.Voice biomarkers may become powerful tools for early cognitive assessment.Deep learning can refine prognosis and reveal hidden tumor patterns.ResourcesHamamatsu (MoxiePlex) • Biocare Medical (ONCORE Pro X) • SITC Programs • Recent publications on AI biomarkers and computational pathology.Thanks for listening—and for being part of this growing digital pathology community.Support the showGet the "Digital Pathology 101" FREE E-book and join us!

UROONCO RCC associate editor Assoc. Prof. Carlotta Palumbo (IT) talks with medical oncologist Dr. Pasquale Rescigno (GB) about his presentation supporting the 'yes' position in the debate at EMUC25: “Is single agent TKI (tyrosine kinase inhibitor) still an option in selected mRCC patients? This interview was recorded at EMUC25 in Prague. For more updates on kidney cancer, please visit our educational platform UROONCO RCC.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Welcome to Ozempic Weightloss Unlocked. Today, we are diving into the latest news and updates on Ozempic, a drug reshaping how we think about weight loss, health, and lifestyle.In the past year, millions of people have turned to Ozempic, part of a group of medications called GLP-1 receptor agonists. Originally created to manage blood sugar for people with type 2 diabetes, Ozempic's appetite-suppressing effects have made it a sought-after tool for weight management. According to the Pennington Biomedical Research Center, these medications were developed from a compound first found in the saliva of the Gila monster lizard. It is amazing to think that a hormone from a desert reptile is now changing lives in clinics around the world.One of the most important updates is accessibility. The White House recently announced a deal with drug makers Eli Lilly and Novo Nordisk to cut prices for Ozempic and related drugs. The average monthly cost, once more than one thousand dollars, could now be as low as fifty to three hundred fifty dollars a month, depending on your insurance. Kim Fisher of the UC Davis Innovation Institute for Food and Health says around one in eight adults in the United States—about forty-one million people—have already used GLP-1 drugs. Lower prices open the door for many more people to take advantage of these treatments.For listeners looking for alternatives to injections, there is more good news. Novo Nordisk recently released results from a study on an oral pill version of Ozempic's sister drug, Wegovy. The New England Journal of Medicine reports that this once-daily pill resulted in an average weight loss of sixteen point six percent—almost identical to the weekly injection. While the pill is not yet approved by the Food and Drug Administration, it may become a game-changer for those seeking a needle-free option. Novo Nordisk says they hope to set a new benchmark for oral weight loss medications pending approval.If you are wondering whether these drugs only affect the scale, the answer is no. According to research from UC Davis and the University of California San Diego, GLP-1 drugs not only promote weight loss, but may also offer broader health benefits. Some of the latest studies show that these medications can lower cardiovascular risk, benefit blood pressure, and even reduce the risk of major events like heart attacks and stroke.Researchers at UC San Diego found that GLP-1 use among people with colon cancer was tied to much lower death rates—fifteen point five percent for those on the drugs, versus thirty-seven point one percent for those who were not. While the exact reasons are still being studied, experts believe these medications reduce inflammation, improve insulin sensitivity, and might even directly inhibit the growth of cancer cells.The way GLP-1 drugs work is by mimicking a natural hormone produced in your gut after eating. They help your body feel full longer, lower blood sugar, and curb cravings—especially for sweets and fatty foods. Patients often report that the constant mental chatter about food is quieter, making it easier to stick to healthy habits.With all the benefits, it is important to mention common side effects. Many users experience nausea, vomiting, or diarrhea, particularly when starting or increasing doses. Doctors recommend pairing treatment with a nutrient-dense diet, regular exercise, and enough protein to help preserve muscle mass.Experts are also discussing the need for ongoing research into the long-term effects and best practices for managing side effects. As these drugs become more widely used, scientists are working to make sure weight loss translates into lasting improvements for health and well-being.That is all for today's episode of Ozempic Weightloss Unlocked. Thank you for tuning in. To stay up to date on the next wave of news and breakthroughs, remember to subscribe. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

In today's VETgirl online veterinary CE podcast, we talk to Dr. Jason Stull, VMD, MPVM, PhD, DACVPM, Associate Professor in Veterinary Medicine at the University of Prince Edward Island about Echinococcus multilocularis and the growing prevalence in veterinary medicine. Tune in as Dr. Stull reviews this potentially zoonotic parasite, how to diagnosis and treat pets with it, and how to communicate with the pet owner about this One Health risk.Sponsored By: Elanco

The FiltrateJoel Topf‍ ‍@kidneyboy.bsky.social‬Sophia Ambruso @sophia-kidney.bsky.socialNayan Arora @captainchloride.bsky.socialSpecial Guests Brian Rifkin @brianrifkin.bsky.socialAnna Gaddy @AnnaGaddyEditing and Show Notes byJoel TopfThe Kidney Connection written and performed by Tim YauShow NotesBrian Rifkin and Cristina Popa ascend to co-editors in chief of NephJC.Paresh Jadav receives the first NephJC Champion award. Dr. Jadav hosted the NephJC night and saved NephJC thousands of dollars. It makes a huge difference in our fund raising. Thank you.Also a big thank-you to Jade Teakell for buying the cowboy hats!The first pick of the draft, by Sophia is Fish oil for dialysis: Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis (NEJM)The second pick, by Brian is FINE-ONE (Bayer Press release)Rajiv Agarwal's mediation analysis to show how much of finerenone's beneficial renal effects are captured by the reduction proteinuria: Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis (PubMed)Anna has the third pick and it goes to Katherine Tuttle and the REM0DEL Trial: REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide (Science Direct)Nayan goes off-board and picks a poster by a med student (backed by Testani)Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure (ClinicalTrials.gov)For the final pick in the draft Joel went with a little Lilly on Lilly violence: Tirzepatide vs. Dulaglutide Is Associated with Reduced Major Kidney Events in Patients with Type 2 Diabetes, CVD, and Very High-Risk Kidney Diseases (JASN)Bring out your dead…What's left on the draft board.Liberate-D A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial (JAMA)Atacicept for IgAN A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy (NEJM)Lilia Cervantes crushed it with Community Health Worker Support for Hispanic and Latino Individuals Receiving Hemodialysis: The Navigate-Kidney Randomized Clinical Trial (JAMA)Tubular SecretionBrian: Late Breaking and High Impact Clinical Trials. Including Sibe! REGENCY Biopsy Data.Sophia: Flying Home. No, really it's the Electrolyte QuizJoel: The Poster Session, the Quiz Session, and Nayan: Flying to AHA to talk about dual-heart-kidney-transplantAnna: Kidney STARS! and Melanie Hoenig's session on potassium

Dr. Centor discusses a family perspective on palliative care with Ms. Monica Wright, the author of an On Being a Patient essay.

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)Ever wondered what it's truly like to live with type 2 diabetes every day?It's more than tracking numbers or following a meal plan—it's the quiet, constant awareness that stays with you from morning to night.This week's episode dives into that reality with someone who knows it best: Danielle Batiste—a proud mom and veteran, who lives with type 2 diabetes. She has turned her diagnosis into a mission to help others live with confidence and grace. Through her Instagram page Diabetes Made Better and her book Let Go My Glucose: Winning with Type 2, she shares practical tools, motivation, and real-life insight to help people thrive—not just stay in range, but live fully.In our conversation, Danielle talks about the emotional ups and downs of diabetes, the power of mindset, and how connection and community can make all the difference. She also shares the strategies that help her manage stress, use modern tools like continuous glucose monitors, and stay in tune with what her body needs.Whether newly diagnosed, living with diabetes for years, or supporting someone who is, Danielle's story offers both perspective and encouragement. Check out the full episode to discover the habits, mindset shifts, and tools that help her live better with diabetes.Connect with Danielle:Instagram: diabetesmadebetterWebsite: diabetesmadebetterGlucose Goal PlannerBook:Let Go My Glucose: Winning with Type 2Book:Diabetes Made Better Connect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.com

Ian Thomas preaches on 2 Peter 3:11-3 on Sunday, November 16, 2025.Main Idea:  Though he feels delayed, God is patiently keeping his promises for those waiting in repentance, holiness, and godliness.Click here for full sermon notes!

In this episode of Life Stories: People Helping People, host Shara Goswick sits down with Frankie Casey, co-founder of Floss, a groundbreaking new platform using emotional intelligence to match patients with the right dentist.Frankie shares his journey from a 22-year career in wealth management to launching a tech-driven healthcare startup alongside his wife, a practicing dentist in London. Together, they set out to solve a real problem—why millions of people avoid or ghost their dental appointments.Through this conversation, Frankie reveals how emotional intelligence, trust, and empathy can transform not just patient experiences but entire industries.Find out more about Floss here: https://floss-dental.co.ukWant to be a guest on Life Stories Podcast?Send Shara Goswick a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/1718977880777072342a16683

In this episode, Eric Grone and Jonathan Aguiar walk through how a flexible patient access platform blends AI, automation, and human expertise to handle eligibility, prior authorizations, and patient estimates at scale. They break down how health systems can configure hybrid models by payer and modality, reduce denials, and unlock analytics that finally make payer friction visible and fixable.

Ditch The Pills: How Integrative Medicine Could Change Your Life These days, there's a pill to solve nearly every problem, but the actual issue may be our growing dependence on these pharmaceuticals. A different approach known as integrative medicine encourages treating the root causes of illness. Our experts this week explain how lifestyle changes, nutrition, and better patient-doctor relationships can finally give us lasting, full-body health. “We Just Listen To Doctors”: Being An Informed Patient Can Save Your Life After losing her son to an opioid overdose, one mother has turned her grief into action by creating a new kind of hospital role – life care specialists. These “care coaches” guide patients through recovery, offering pain management education, emotional support, and alternatives to addictive medications. Medical Notes: Why A Deep Breath Could Save Your Life, The Truth Behind Video Game Addiction, And How To Get ‘FOREVER Chemicals' Out Of Your Water Here's the best way to increase your vitamin-d during winter. Should you be taking a weight loss drug for alcohol addiction? Hormone replacement may not just be for menopause treatment. Is air pollution affecting your metabolism? Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the PFC Podcast, Dennis and Kevin discuss the complexities of using narcotics in long-term care, particularly in a military or austere environment. They delve into the importance of understanding drug metabolites, context-sensitive half-times, and the implications for patient care. The conversation covers various anesthetic agents, their effects, and the clinical considerations necessary for effective pain management and sedation during and after surgical procedures.TakeawaysMetabolites of narcotics can significantly impact patient care.Fentanyl infusions can provide prolonged analgesia but require careful monitoring.Midazolam has a longer context-sensitive half-time compared to other anesthetics.Morphine's metabolite can lead to increased potency and potential overshooting.Dilaudid is preferred over morphine for its predictability in effects.Vecuronium's metabolite can cause prolonged neuromuscular blockade, especially in renal impairment.Ketamine can have unexpected, prolonged effects postoperatively.Timing of drug administration is crucial in prolonged field care scenarios.Patients with low urine output may require adjusted medication dosages.Understanding context-sensitive half-times is essential for effective anesthesia management.Chapters00:00 Introduction to Narcotics in Long-Term Care01:43 Understanding Metabolites and Context-Sensitive Half-Time05:02 Fentanyl Infusions and Prolonged Analgesia06:54 Comparing Anesthetic Agents: Midazolam, Ketamine, and Propofol10:11 Clinical Implications of Metabolites in Anesthesia13:27 Challenges with Ketamine and Other Narcotics16:03 Timing and Context-Sensitive Half-Time in Anesthesia20:39 Managing Post-Operative Pain and Sedation23:29 Key Takeaways on Metabolites and Infusion TimingFor more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠

I. The Priority of Love, vv1-3. II. The Practices of Love, vv4-7. III. The Permanence of Love, v8a.

WNBA legend and Project B co-founder and Chief Basketball Officer Alana Beard joins Sarah to discuss the origins of the Project B women's basketball league, how Alana’s international experience as a player informs her new gig, the league’s much-talked-about partnership with a company owned by the Saudi-owned Public Investment Fund, and when we can expect to get more player announcements. Plus, DC vs. NYC, the Rise of Vancouver, and will the real SC please stand up? SHOW NOTES: Follow Alana Beard on Instagram @alanabeard Follow Project B on Instagram @projectb_global Leave us a voicemail at 872-204-5070 or send us a note at goodgame@wondermedianetwork.com Follow Sarah on social! Bluesky: @sarahspain.com Instagram: @Spain2323 Follow producer Alex Azzi! Bluesky: @byalexazzi.bsky.social Instagram: @AzziArtwork See omnystudio.com/listener for privacy information.

Patient messaging has become more common across health systems, but few use it in a way that truly supports better health outcomes. Northwestern Medicine's Smart Outreach for Better Health is taking patient communication a step further by using automation to identify specific populations and send personalized clinically relevant messages. Our host Myesha Williams and Northwestern's Program Manager Dharmesh Patel share how this initiative bridges care gaps, boosts follow up rates and helps patients stay engaged in their own care.   Guest speaker: Dharamesh Patel Program Manager, Quality and Patient Safety Northwestern Medicine    Host: Myesha Williams SN, RN Fellow, Performance Improvement Programs Vizient   Show notes: [00:56] – Overview of the Better Health initiative and how patient messaging was deployed [01:53] – Collaboration between data and quality leaders that launched automated patient outreach [03:17] – Implementing a systemwide strategy to enhance outreach and care coordination [04:19] – Timing messages to reach patients when they're most likely to respond [06:32] – Role of patient and family advisors in driving success and credibility [07:40] – How the team increased follow-through rates, engaging 13% of patients [09:12] – Tackling challenges and leveraging EMR analyst expertise [09:54] – Addressing time constraints as a key project barrier   Links | Resources: Contacting Knowledge on the Go: picollaboratives@vizientinc.com   Subscribe Today! Apple Podcasts Spotify YouTube Android RSS Feed  

December 2025 Journal Club Podcast Title: Association Between Operative Neurosurgical Intervention and Favorable Discharge Among Patients With Traumatic Subdural Hematoma and Poor Neurological Examination To read journal article: jhttps://journals.lww.com/neurosurgery/fulltext/2025/12000/association_between_operative_neurosurgical.15.aspx Author: Tej Azad Guest Faculty: Ryan Kitagawa Moderator: Laura Zima Committee Co-Chair: Rafael Vega

Psilocybin is a psychedelic chemical derived from mushrooms.  It is under study for mood problems in people with ALS.  Here we review its plausible mechanisms for slowing ALS progression.  But there are no data from preclinical models, trials or case reports that currently support this benefit.  And there can be serious risks to using this chemical.

☕ DECAF Trial insight! A new JAMA study shows that daily caffeinated coffee may lower recurrence of atrial fibrillation compared with abstinence. Patients drinking ~1 cup/day had 47% recurrence vs 64% with abstinence (HR 0.61, p=0.01)

BUFFALO, NY – November 17, 2025 – A new #research perspective was #published in Oncotarget (Volume 16) on November 14, 2025, titled “A personal perspective of patient-centred clinical trials.” In this perspective, led by corresponding author Jia Liu of The Kinghorn Cancer Centre, St Vincent's Hospital, the University of New South Wales, and the Garvan Institute of Medical Research, three early-phase clinical trial participants — Trevor Tyne, Elizabeth Ivimey, and Leanne Duggan — reflect on their personal experiences with experimental cancer treatments. Their stories offer a unique perspective on the patient journey through early-phase trials and emphasize the need to design clinical research that prioritizes patients' needs, dignity, and lived realities. The authors highlight both the life-changing opportunities that trials can provide and the systemic barriers that still prevent many patients from participating. This perspective captures a turning point in how early-phase trials are viewed. Once considered a last resort, these trials are now increasingly offered earlier in treatment, especially with the rise of biomarker-guided therapies. In this context, the patient experience has become critical. The authors outline key benefits of participation, including access to novel therapies, ongoing medical monitoring, emotional support, and a strong sense of purpose in contributing to future medical advancements. However, they also point out significant challenges, such as restrictive eligibility criteria, high financial and logistical burdens, and communication gaps between patients and trial staff. “While no trial guarantees success, the level of support, access to innovative therapies, and sense of contribution to medical progress can be profoundly meaningful.” Each narrative provides insight into the clinical trial experience. One patient explains how living with a visual impairment required tailored accessibility support throughout the trial process Another shares how genomic testing led to targeted treatment after standard options failed. Despite their different diagnoses and circumstances, all three stories reflect resilience, hope, and a shared call for trial designs that better reflect the realities of diverse patients. To address these issues, the authors propose a number of improvements to trial design and delivery. These include expanding eligibility criteria, offering financial and logistical assistance, improving communication training for research staff, and introducing dedicated trial navigators to help guide patients through complex processes. They also focus on the importance of involving patient advocates in trial design and ensuring smoother transitions for patients moving between treatment centers. While early-phase trials focus on safety and effectiveness, the authors argue they must also be guided by core values like ethics and patient empowerment. This perspective serves as a reminder that the future of cancer research depends not only on scientific innovation, but on an honest partnership between patients and the research community. By sharing these real-world experiences, the article encourages a broader conversation about how to make clinical trials more responsive to the people they are designed to serve. DOI - https://doi.org/10.18632/oncotarget.28776 Correspondence to - Jia Liu - jia.liu@svha.org.au Abstract video - https://www.youtube.com/watch?v=2CCGN78n8ug To learn more about Oncotarget, visit https://www.oncotarget.com: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Antoine Pivron, Vice President of Health Solutions in the B2B division at Withings, highlights the clinical-grade connected devices that are changing the remote patient monitoring market. The equipment and AI-enhanced tools are designed to focus on personalized patient engagement and retention, ultimately leading to improved health outcomes. The data made available identifies trends over time, allowing for intervention when necessary, and is presented in a form that emphasizes prevention rather than reaction. Antoine explains, "We are very well known for our connected devices, especially the weight scales. So we were the first company back in 2009 to develop a connected weight scale, and now we are the leader in this field, mainly in Europe and in the US. So I think we might have the broadest ecosystem of connected devices to be honest, on the market. So we have weight scales, but we also have blood pressure monitors, activity trackers with smart watches. We also have urine analyzers that we're going to launch next week, actually. We really do have a huge range of products that can be used at home to remotely monitor patients."   "They're actually analyzing the trends over weeks, months, and they have an intervention when there is something that is not going in the right direction. So it's more about managing alerts if needed. For instance, in chronic heart failure, most remote patient monitoring programs, doctors manage alerts only. And for obesity care, it might be like coaches or nutritionists having a one-time a week or a one-time a month video call with the patient, and they're just managing the trends. So it's not about being in constant alert, it's about having more data to help them make the right decision." #Withings #DigitalHealth #RemoteMonitoring #ConnectedDevices #MedTech withings.com  Listen to the podcast here